Effect of antihistamine up-dosing in chronic urticaria.
暂无分享,去创建一个
J. Mullol | J. Bartra | A. Del Cuvillo | I. Dávila | I. Jáuregui | J. Montoro | J. Sastre | A. Valero | M. Ferrer
[1] M. Maurer,et al. Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab. , 2010, The Journal of allergy and clinical immunology.
[2] J. Bousquet,et al. Risk of first‐generation H1‐antihistamines: a GA2LEN position paper , 2010, Allergy.
[3] T. Zuberbier,et al. Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi‐centre, double‐blind, randomized, placebo‐controlled study , 2010, Allergy.
[4] Todor A Popov,et al. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. , 2010, The Journal of allergy and clinical immunology.
[5] H. Schünemann,et al. EAACI/GA²LEN/EDF/WAO guideline: management of urticaria , 2009, Allergy.
[6] M. Maurer,et al. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo‐ controlled treatment with rupatadine 10 and 20 mg , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.
[7] T. Zuberbier,et al. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. , 2009, The Journal of allergy and clinical immunology.
[8] A. Kaplan. What the first 10,000 patients with chronic urticaria have taught me: a personal journey. , 2009, The Journal of allergy and clinical immunology.
[9] R. Zeldin,et al. Treatment of chronic autoimmune urticaria with omalizumab. , 2008, The Journal of allergy and clinical immunology.
[10] S. Spector,et al. Omalizumab also successful in chronic urticaria. , 2008, The Journal of allergy and clinical immunology.
[11] C. Grattan,et al. Guidelines for evaluation and management of urticaria in adults and children , 2007, The British journal of dermatology.
[12] L. Dubertret,et al. Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study. , 2007, European journal of dermatology : EJD.
[13] E. Arnáiz,et al. Rupatadine in the treatment of chronic idiopathic urticaria: a double‐blind, randomized, placebo‐controlled multicentre study , 2007, Allergy.
[14] R. Asero. Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above‐licensed doses , 2006, Clinical and experimental dermatology.
[15] G. Vena,et al. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. , 2006, Journal of the American Academy of Dermatology.
[16] T. Zuberbier,et al. EAACI/GA2LEN/EDF guideline: management of urticaria , 2006, Allergy.
[17] P. Auquier,et al. Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life , 2005, The British journal of dermatology.
[18] F. Simons. Advances in H1-antihistamines. , 2004, The New England journal of medicine.
[19] A. Kaplan. Chronic urticaria: pathogenesis and treatment. , 2004, The Journal of allergy and clinical immunology.
[20] G. W. Canonica,et al. Consensus group on new‐generation antihistamines (CONGA): present status and recommendations , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[21] F. Simons,et al. Clinical pharmacology of H1-antihistamines in the skin. , 2002, The Journal of allergy and clinical immunology.
[22] A. Kaplan,et al. Secretion of Cytokines, Histamine and Leukotrienes in Chronic Urticaria , 2002, International Archives of Allergy and Immunology.
[23] R. Leurs,et al. H1‐antihistamines: inverse agonism, anti‐inflammatory actions and cardiac effects , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[24] A. Kay,et al. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. , 2002, The Journal of allergy and clinical immunology.
[25] P. Seed,et al. Randomized double‐blind study of cyclosporin in chronic ‘idiopathic’ urticaria , 2000, The British journal of dermatology.
[26] H. Nelson,et al. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[27] A. Kaplan,et al. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. , 1999, The Journal of allergy and clinical immunology.
[28] M. Emanuel. Histamine and the antiallergic antihistamines: a history of their discoveries , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[29] M. Morgan,et al. The impact of chronic urticaria on the quality of life , 1997, The British journal of dermatology.
[30] J. Q. Rosso,et al. Chronic urticaria: do urticaria nonexperts implement treatment guidelines? A survey of adherence to published guidelines by nonexperts , 2010 .
[31] T. Zuberbier,et al. Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria : a multi-centre , double-blind , random-ized , placebo-controlled study , 2010 .
[32] M. Ferrer. Epidemiology, healthcare, resources, use and clinical features of different types of urticaria. Alergológica 2005. , 2009, Journal of investigational allergology & clinical immunology.
[33] Suephy C. Chen,et al. Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients. , 2008, Archives of dermatology.
[34] M. T. Caballero,et al. Epidemiology of urticaria in Spain. , 2004, Journal of investigational allergology & clinical immunology.
[35] T. Zuberbier,et al. Double-blind crossover study of high-dose cetirizine in cholinergic urticaria. , 1996, Dermatology.